Kestra Private Wealth Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

Kestra Private Wealth Services’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-287,702	Closed	-$2.16M	–	903
2022 Q3	$2.16M	Sell	287,702 -294,208	-51%	-$2.55M	0.13%	188
2022 Q2	$5.85M	Hold	581,910	–	–	0.33%	70
2022 Q1	$7.2M	Buy	+581,910	New	+$8.99M	0.36%	63
2021 Q4	–	Sell	-801,100	Closed	-$17.7M	–	990
2021 Q3	$17.7M	Buy	+801,100	New	+$12.7M	0.99%	8
2021 Q1	–	Sell	-406,000	Closed	-$5.67M	–	800
2020 Q4	$5.67M	Buy	406,000 +106,000	+35%	+$1.54M	0.42%	53
2020 Q3	$4.19M	Buy	+300,000	New	+$4.35M	0.36%	67

Other funds holding AUPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kestra Private Wealth Services's AUPH Position: Q4 2022 in Review

Kestra Private Wealth Services sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 287,702 shares — an estimated $2.16M sold.

Kestra Private Wealth Services first reported a position in AUPH in Q3 2020 and held it in 6 quarters. The position peaked at $17.7M in Q3 2021. 192 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

Kestra Private Wealth Services reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Kestra Private Wealth Services sold 287,702 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $2.16M.
Kestra Private Wealth Services first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 6 quarters.
Kestra Private Wealth Services's Aurinia Pharmaceuticals position peaked at $17.7M in Q3 2021.
192 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on Kestra Private Wealth Services's 13F filing for Q4 2022, filed 1 Feb 2023.